Neurodevelopmental risks are assessed using a combination of epidemiological studies, animal models, and in vitro systems. Epidemiological studies help establish associations between exposure and outcomes in humans, while animal models provide mechanistic insights. In vitro systems, such as cell cultures, allow for high-throughput screening of potential neurotoxic agents.
